Chairman and Director
Virginia Tech Carilion School of Medicine, USA
Allal Boutajangout has completed his PhD at Free University of Brussels, School of Medicine (ULB-Erasme Hospital) in 2005 and Postdoctoral training at New York University School of Medicine. He is a Research Associate Professor of Neurology and Neuroscience & Physiology and Psychiatry. He is also the chief of Neurodegeneration and Drug Discovery Program within Center for Cognitive Neurology at NYU. He has published more than 30 papers in reputed journals and serves as a reviewer for many scientific journals.
Alzheimer's & Dementia